Tuberculosis (TB)

Annex 2. Methods

A2.2 Implementing the Stop TB Strategy (2006-2008)

The information on implementing and planning the Stop TB Strategy presented and analysed in this report reflects activities mostly carried out in the 2006–2007 fiscal year and planned for the 2007–2008 fiscal year (see also A2.3 Financing TB control). For the first time in 2007, all data were requested via the same questionnaire as that used for the collection of the surveillance, epidemiological and financial data described in A2.1 and A2.3.1 In previous years, a separate questionnaire had been sent to HBCs. As with questions on surveillance, epidemiological and financial data, questions on planning and implementation of the Stop TB Strategy were sent to all countries, although there was a more extended set of questions for HBCs.

The questionnaire was structured around the major components and subcomponents of the Stop TB Strategy and included questions on: DOTS expansion and enhancement, including laboratory and diagnostic services, standardized treatment and patient support, drug management, and monitoring and evaluation including impact measurement; collaborative TB/HIV activities; drug-resistant TB; special populations and other high-risk groups; health system strengthening and TB control, including human resource development, the Practical Approach to Lung Health (PAL), the extent to which TB control activities are integrated into primary health-care services, and the links between planning for TB control and broader planning frameworks and initiatives at the level of the health or public sector as a whole; public–public and public–private mix (PPM) approaches; International Standards for Tuberculosis Care;2 advocacy, communication and social mobilization (ACSM); community TB care; Patients’ Charter for Tuberculosis Care;3 and operational research.

Completed questionnaires were reviewed at all levels of WHO by country offices, regional offices and at headquarters. The acknowledgement form described above in A2.1 included follow-up queries regarding missing data or questions of clarification from submitted questionnaires. For HBCs, data were also used to produce the strategy component of the country profiles presented in Annex 1. This profile was discussed with NTP managers during international and regional meetings wherever possible, and with WHO staff with particular expertise or knowledge of each country. These discussions are used to produce a final version of the profile, which is sent to the NTP for their review and approval. Any clarifications or corrections provided at this stage are incorporated by WHO staff at headquarters.

Additional details about data collection or analysis that are specific to DOTS implementation, collaborative TB/HIV activities and diagnosis and treatment of MDR-TB are provided below.


Footnotes

1 Posted at www.who.int/tb/country/en/

2 Hopewell PC et al. International standards for tuberculosis care. Lancet Infectious Diseases. 2006, 6:710-725.

3 Posted at www.who.int/tb/publications/2006/istc/en/index.html

Share